Thursday, 29 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14778
Articles
Policy / Regulatory
NMPA Releases 89th Batch of Reference Drugs for GQCE Work
January 10, 2025
Policy / Regulatory
China’s NHC Aims for Over 90% Child-Friendly Hospitals by 2030
January 10, 2025
Company
Deals
Stryker to Acquire Inari Medical for USD 4.9 Billion to Boost VTE Pipeline
January 10, 2025
Company
Drug
GSK Launches Cabotegravir Injection in China for HIV Pre-Exposure Prophylaxis
January 10, 2025
Company
Deals
Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong
January 10, 2025
Company
Deals
Haier Biomedical Terminates Acquisition Plan for Shanghai RAAS
January 9, 2025
Company
Drug
NHSA Revises 2024 NRDL Drug Information Based on Public Feedback
January 9, 2025
Company
Eli Lilly China’s Neuroscience VP Jiang Yifei Departs for New Opportunities
January 9, 2025
Company
Deals
Fourier Intelligence Secures USD 109 Million in Series E Funding for Robotics Innovation
January 9, 2025
Company
Drug
Astellas’ Padcev and Keytruda Combo Cleared by NMPA for Urothelial Cancer
January 9, 2025
Company
Drug
HuidaGene Therapeutics Receives EMA Orphan Designation for HG004 Gene Therapy
January 9, 2025
Company
Deals
China Medical System Licenses Alpha Cognition’s Zunveyl for Dementia Treatment in Asia
January 9, 2025
1
2
…
506
507
508
509
510
…
1,231
1,232
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?